Related Experiment Video
Updated: Jun 1, 2026

A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells
Published on: October 15, 2013
Recent patents of nanodevices for single cell immunological assays
1Department of Chemical Engineering, The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. jonghoon@mit.edu
Insights
Recent patents showcase nanodevices for isolating and characterizing single immune cells. This review suggests new strategies to advance nanodevice capabilities for studying human immune diseases.
Area of Science:
- Biomedical Engineering
- Immunology
- Nanotechnology
Background:
- Single immune cell analysis is crucial for understanding immune responses and diseases.
- Existing nanodevices offer promising platforms for immune cell isolation and characterization.
- Patents represent key innovations in the development of these advanced tools.
Purpose of the Study:
- To review recent patents on nanodevices for single immune cell isolation and characterization.
- To identify common categories and strategies employed in current nanodevice designs.
- To propose novel approaches for enhancing nanodevice capabilities in immune disease research.
Main Methods:
- Comprehensive literature search of recent patents related to nanodevices for single cell analysis.
- Categorization of patented nanodevices based on their design principles and assay types.
- Analysis of the strengths and limitations of existing nanotechnologies for immune cell studies.
Main Results:
- Identification of key patented nanotechnologies for isolating and characterizing individual immune cells.
- Overview of prevalent single cell assay formats integrated with nanodevices.
- Emerging trends in nanodevice design for enhanced sensitivity, specificity, and throughput.
Conclusions:
- Nanodevices are rapidly evolving for precise single immune cell analysis.
- Further innovation is needed to fully leverage nanotechnologies for complex human immune disease studies.
- Future nanodevice development should focus on expanding assay multiplexing and in situ analysis capabilities.
Abstract:
This review focuses on recent patents for the design and implementation of nanodevices to isolate and characterize single immune cells. Specifically, the most common categories of single cell assays were reviewed and new strategies were suggested to expand the capabilities of nanodevices further for the study of human immune disease.

